The investment case for cervical cancer elimination. (July 2017)

• Record Type: Journal Article
• Authors: Tsu, Vivien Davis; Ginsburg, Ophira
• Is Part Of: International journal of gynaecology and obstetrics. Volume 138(2017)Supplement 1
• Page Start: 69
• Page End: 73
• Publication Date: 2017-07
• Subjects: Cervical cancer -- Disease elimination -- Low‐income countries -- Prevention; Gynecology -- Periodicals; Obstetrics -- Periodicals; Electronic journals; 618
• DOI: 10.1002/ijgo.12193
• Languages: English
• ISSNs: 0020-7292

Abstract

Abstract: We already know what causes cervical cancer, how to prevent it, and how to treat it, even in resource‐constrained settings. Inequitable access to human papillomavirus vaccine for girls and screening and precancer treatment for women in low‐ and middle‐income countries is unacceptable on ethical, social, and financial grounds. The burden of cervical cancer falls on the poor and extends beyond the narrow bounds of the family, affecting national economic development and community life, as family resources are drained and poverty tightens its grip. Proven solutions are available and the priorities for the next few years are clear, as shown by the papers in this Supplement. Sustained political commitment and strategic investments in cervical cancer prevention can not only save millions of lives over the next 10 years, but can also pave the way for the broader fight against all cancers. Abstract : The inequitable burden of cervical cancer could be eliminated with solutions already available. Sustained political commitment and strategic investments in the next few years could make this a reality.